Frances joined EyeBio as Head of Clinical Operations in September 2022. In this role, Frances is responsible for clinical operations worldwide to ensure the successful delivery of clinical studies.
Frances has a 30-year career in clinical development. Prior to joining EyeBio, Frances worked in clinical research developing products in oncology, virology, and ophthalmology for a range of companies. Earlier in her career, Frances worked at Roche for over 10 years and participated in the successful filing of Roferon®, Neupogen®, and MabThera®. Following Roche, she subsequently joined Eyetech and was part of the team developing Macugen.
In recent years Frances has supported many studies to develop products in ophthalmology ranging from first in human Phase I studies to large global Phase III studies.
